COSMOS Pharmaceutical Corporation (CSMYF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 01:24PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.81B |
| Enterprise value | 3.75B |
| Trailing P/E | 21.66 |
| Forward P/E | 20.12 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.66 |
| Price/book (mrq) | 2.59 |
| Enterprise value/revenue | 0.00 |
| Enterprise value/EBITDA | 0.11 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.13 |
| 52-week change 3 | 0.00% |
| S&P500 52-week change 3 | 25.77% |
| 52-week high 3 | 98.32 |
| 52-week low 3 | 98.32 |
| 50-day moving average 3 | 98.32 |
| 200-day moving average 3 | 98.32 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 39.63M |
| Implied shares outstanding 6 | 39.6M |
| Float 8 | 17.91M |
| % held by insiders 1 | 51.54% |
| % held by institutions 1 | 22.01% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 57.50 |
| Trailing annual dividend yield 3 | 58.48% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 13.54% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 30 May 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 28 May 2020 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 May 2023 |
| Most-recent quarter (mrq) | 29 Feb 2024 |
Profitability
| Profit margin | 2.66% |
| Operating margin (ttm) | 3.31% |
Management effectiveness
| Return on assets (ttm) | 4.91% |
| Return on equity (ttm) | 11.63% |
Income statement
| Revenue (ttm) | 936.71B |
| Revenue per share (ttm) | 23,646.83 |
| Quarterly revenue growth (yoy) | 18.10% |
| Gross profit (ttm) | N/A |
| EBITDA | 50.76B |
| Net income avi to common (ttm) | 24.87B |
| Diluted EPS (ttm) | 4.54 |
| Quarterly earnings growth (yoy) | 15.80% |
Balance sheet
| Total cash (mrq) | 18.45B |
| Total cash per share (mrq) | 465.57 |
| Total debt (mrq) | 10.7B |
| Total debt/equity (mrq) | 4.77% |
| Current ratio (mrq) | 0.61 |
| Book value per share (mrq) | 5,659.52 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.